Concepedia
Statistics
Publications
5
Citations
164
H-Index
Active since
2021
Affiliations
Université Paris Cité(Current)
Assistance Publique – Hôpitaux de Paris
Institut Necker Enfants Malades
Inserm
Hôpital Femme Mère Enfant
Lola Zerbib is an author at Université Paris Cité specializing in gene therapies, thrombosis, and vascular biology.
Top concepts
MedicinePathologyThrombosisAngiogenesisGene TherapyPharmacologyVascular BiologyMolecular SignalingMolecular PharmacologyInherited Metabolic Disease
Publications per year
2021–2024
Alpelisib administration reduced lymphatic malformations in a mouse model and in patients
Florence Delestre, Quitterie Venot, Charles Bayard et al. · Science Translational Medicine · 2021 · 81 citations
PIK3CA gain-of-function mutation in adipose tissue induces metabolic reprogramming with Warburg-like effect and severe endocrine disruption
Sophia Ladraa, Lola Zerbib, Charles Bayard et al. · Science Advances · 2022 · 30 citations · Full text
Sotorasib for Vascular Malformations Associated with <i>KRAS</i> G12C Mutation
Antoine Fraissenon, Charles Bayard, G Morin et al. · New England Journal of Medicine · 2024 · 25 citations
Targeted therapy for capillary-venous malformations
Lola Zerbib, Sophia Ladraa, Antoine Fraissenon et al. · Signal Transduction and Targeted Therapy · 2024 · 18 citations · Full text
Vascular Malformation, Pathology, Vascular Malformations +16
Hemifacial myohyperplasia is due to somatic muscular PIK3CA gain-of-function mutations and responds to pharmacological inhibition
Charles Bayard, E. Segna, M.A.M. Taverne et al. · The Journal of Experimental Medicine · 2023 · 10 citations · Full text
1–5 of 5